Med Life Future Growth

Future criteria checks 5/6

Med Life is forecast to grow earnings and revenue by 88.1% and 11.3% per annum respectively. EPS is expected to grow by 1.8% per annum. Return on equity is forecast to be 21.9% in 3 years.

Key information

88.1%

Earnings growth rate

1.8%

EPS growth rate

Healthcare earnings growth25.0%
Revenue growth rate11.3%
Future return on equity21.9%
Analyst coverage

Low

Last updated10 Sep 2024

Recent future growth updates

Recent updates

Is Med Life S.A. (BVB:M) Trading At A 41% Discount?

Aug 06
Is Med Life S.A. (BVB:M) Trading At A 41% Discount?

The Market Lifts Med Life S.A. (BVB:M) Shares 25% But It Can Do More

Jun 08
The Market Lifts Med Life S.A. (BVB:M) Shares 25% But It Can Do More

Is Med Life (BVB:M) A Risky Investment?

Apr 05
Is Med Life (BVB:M) A Risky Investment?

Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)

Jul 05
Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)

Is Med Life (BVB:M) A Risky Investment?

Jan 06
Is Med Life (BVB:M) A Risky Investment?

Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns

Dec 06
Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns

We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt

Sep 27
We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt

Returns Are Gaining Momentum At Med Life (BVB:M)

May 05
Returns Are Gaining Momentum At Med Life (BVB:M)

Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?

Mar 01
Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?

Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue

Jan 22
Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue

Does Med Life (BVB:M) Have A Healthy Balance Sheet?

Aug 31
Does Med Life (BVB:M) Have A Healthy Balance Sheet?

Med Life's (BVB:M) Returns On Capital Are Heading Higher

Jun 10
Med Life's (BVB:M) Returns On Capital Are Heading Higher

Here's Why We Think Med Life (BVB:M) Is Well Worth Watching

May 26
Here's Why We Think Med Life (BVB:M) Is Well Worth Watching

Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?

May 12
Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?

Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?

Apr 12
Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?

Update: Med Life (BVB:M) Stock Gained 98% In The Last Year

Mar 16
Update: Med Life (BVB:M) Stock Gained 98% In The Last Year

Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?

Mar 04
Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?

Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?

Feb 20
Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?

Med Life (BVB:M) Seems To Use Debt Quite Sensibly

Feb 07
Med Life (BVB:M) Seems To Use Debt Quite Sensibly

Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?

Jan 25
Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?

Do Med Life's (BVB:M) Earnings Warrant Your Attention?

Jan 08
Do Med Life's (BVB:M) Earnings Warrant Your Attention?

Is Med Life S.A. (BVB:M) Trading At A 22% Discount?

Dec 23
Is Med Life S.A. (BVB:M) Trading At A 22% Discount?

Did You Miss Med Life's (BVB:M) 49% Share Price Gain?

Dec 08
Did You Miss Med Life's (BVB:M) 49% Share Price Gain?

The Trends At Med Life (BVB:M) That You Should Know About

Nov 24
The Trends At Med Life (BVB:M) That You Should Know About

Earnings and Revenue Growth Forecasts

BVB:M - Analysts future estimates and past financials data (RON Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,278163393N/A1
12/31/20252,92980295N/A1
12/31/20242,61124N/AN/A1
9/30/20242,5662210272N/A
6/30/20242,4611826274N/A
3/31/20242,33711-15223N/A
12/31/20232,2224-36184N/A
9/30/20232,116-1140268N/A
6/30/20232,020-3-10179N/A
3/31/20231,9211223212N/A
12/31/20221,8103215185N/A
9/30/20221,7256410112N/A
6/30/20221,6238083202N/A
3/31/20221,52098122209N/A
1/1/20221,438103130227N/A
9/30/20211,359107103185N/A
6/30/20211,29511267172N/A
3/31/20211,1608347148N/A
1/1/20211,0875740129N/A
9/30/20201,0333649145N/A
6/30/20209741677134N/A
3/31/20201,0071863113N/A
12/31/20199751454107N/A
9/30/2019939203276N/A
6/30/2019902162871N/A
3/31/201986111N/AN/AN/A
1/1/201980413-152N/A
9/30/20187458047N/A
6/30/20186995N/A41N/A
3/31/20186575N/AN/AN/A
1/1/20186284N/A36N/A
9/30/20176103N/A42N/A
6/30/2017577-2N/A39N/A
3/31/2017539-6N/AN/AN/A
1/1/2017508-5N/A43N/A
9/30/2016469-1N/A39N/A
12/31/20153969N/A42N/A
12/31/20143377N/A36N/A
12/31/2013306-4N/A23N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: M's forecast earnings growth (88.1% per year) is above the savings rate (6.3%).

Earnings vs Market: M's earnings (88.1% per year) are forecast to grow faster than the RO market (-0.07% per year).

High Growth Earnings: M's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: M's revenue (11.3% per year) is forecast to grow faster than the RO market (1.3% per year).

High Growth Revenue: M's revenue (11.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: M's Return on Equity is forecast to be high in 3 years time (21.9%)


Discover growth companies